EUVIMEDEUVIMED entdecken
Crossref

Comprehensive transcriptomic analysis identifies Lrg1 as a potential therapeutic target for preventing muscle atrophy in cancer cachexia

Hanbi Lee iD, Aeyung Kim iD, Kyuwon Son iD, Ahyoung Choi iD, Seongwon Cha iD, Hyunjin Shin iD, No Soo Kim iD, Haeseung Lee iD

American Journal of Physiology-Cell Physiology · 2026

DOI: 10.1152/ajpcell.00319.2025 ↗

Kurz gefasst

Fachartikel in der Zeitschrift American Journal of Physiology-Cell Physiology, 2026. Verfasst von Hanbi Lee und 7 weiteren Autor:innen. Beteiligte Einrichtung: MOGAM Institute for Biomedical Research, Seoul, Republic of Korea. Hauptthemen laut MEDLINE: Cachexia, Muscular Atrophy, Transcriptome, Glycoproteins. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 71 Literaturangaben. Gefördert von: Ministry of Science and ICT, South Korea (MSIT), Korea Institute of Oriental Medicine (KIOM).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

This study reports the first omics-based characterization of the CT-26 cancer cachexia model and shows transcriptomic concordance with other models. Integrative bulk and single-cell analyses identified Lrg1 as a gene highly expressed in endothelial cells and associated with muscle wasting. Functional assays indicated that extracellular Lrg1 activates Stat3 and induces myotube atrophy, whereas its neutralization or Stat3 inhibition prevented these effects. Lrg1 may therefore serve as a biomarker and therapeutic target in cancer cachexia.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

CachexiaMuscular AtrophyTranscriptomeGlycoproteinsNeoplasmsAnimalsMiceGene Expression ProfilingHumansMuscle, SkeletalSTAT3 Transcription FactorMice, Inbred C57BLMuscle Fibers, SkeletalMaleEndothelial Cells

Stichwörter der Autor:innen

Lrg1cancer cachexiaendothelial cellsmuscle atrophytranscriptomics analysis

Substanzen

LRG1 protein, mouseGlycoproteinsSTAT3 Transcription FactorStat3 protein, mouseLRG1 protein, human

Autor:innen und Institutionen

  • MOGAM Institute for Biomedical Research, Seoul, Republic of Korea.
  • Korean Medicine (KM) Application Center, Korea Institute of Oriental Medicine, Daegu, Republic of Korea.
  • College of Pharmacy and Research Institute for Drug Development, Pusan National University, Busan, Republic of Korea.
  • KM Data Division, Korea Institute of Oriental Medicine, Daejeon, Republic of Korea.
  • KM Convergence Research Division, Korea Institute of Oriental Medicine, Daejeon, Republic of Korea.

ORCID-Profile: Hanbi Lee, Aeyung Kim, Kyuwon Son, Ahyoung Choi, Seongwon Cha, Hyunjin Shin, No Soo Kim, Haeseung Lee

Förderung

  • Ministry of Science and ICT, South Korea (MSIT)
  • Korea Institute of Oriental Medicine (KIOM)

Zitieren

APA

Lee, H., Kim, A., Son, K., Choi, A., Cha, S., Shin, H., Kim, N. S., & Lee, H. (2026). Comprehensive transcriptomic analysis identifies Lrg1 as a potential therapeutic target for preventing muscle atrophy in cancer cachexia. American Journal of Physiology-Cell Physiology. https://doi.org/10.1152/ajpcell.00319.2025

Vancouver

Lee H, Kim A, Son K, Choi A, Cha S, Shin H, et al. Comprehensive transcriptomic analysis identifies Lrg1 as a potential therapeutic target for preventing muscle atrophy in cancer cachexia. American Journal of Physiology-Cell Physiology. 2026. doi:10.1152/ajpcell.00319.2025

BibTeX
@article{Lee2026,
  author = {Lee, Hanbi and Kim, Aeyung and Son, Kyuwon and Choi, Ahyoung and Cha, Seongwon and Shin, Hyunjin and Kim, No Soo and Lee, Haeseung},
  title = {Comprehensive transcriptomic analysis identifies Lrg1 as a potential therapeutic target for preventing muscle atrophy in cancer cachexia},
  journal = {American Journal of Physiology-Cell Physiology},
  year = {2026},
  doi = {10.1152/ajpcell.00319.2025}
}
Kostenlos starten →